PODD vs. ARWR
PODD (Insulet Corporation) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. Both are in the Healthcare sector — PODD in Medical Devices, ARWR in Biotechnology. Over the past 10 years, PODD returned 17.15%/yr vs 31.09%/yr for ARWR. At a 0.26 correlation, their price movements are largely independent.
Performance
PODD vs. ARWR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PODD achieves a -51.11% return, which is significantly lower than ARWR's 23.51% return. Over the past 10 years, PODD has underperformed ARWR with an annualized return of 17.15%, while ARWR has yielded a comparatively higher 31.09% annualized return.
PODD
- 1D
- -4.66%
- 1M
- -10.27%
- YTD
- -51.11%
- 6M
- -52.34%
- 1Y
- -54.16%
- 3Y*
- -21.55%
- 5Y*
- -13.11%
- 10Y*
- 17.15%
ARWR
- 1D
- 0.22%
- 1M
- 9.41%
- YTD
- 23.51%
- 6M
- 18.84%
- 1Y
- 435.25%
- 3Y*
- 32.51%
- 5Y*
- -1.42%
- 10Y*
- 31.09%
PODD vs. ARWR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PODD Insulet Corporation | -51.11% | 8.88% | 20.32% | -26.30% | 10.64% | 4.08% | 49.32% | 115.83% | 14.96% | 83.12% |
ARWR Arrowhead Pharmaceuticals, Inc. | 23.51% | 253.14% | -38.56% | -24.56% | -38.82% | -13.59% | 20.97% | 410.71% | 237.50% | 137.42% |
Correlation
The correlation between PODD and ARWR is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since May 15, 2007 | 0.26 |
The correlation between PODD and ARWR shifts across timeframes, from 0.08 (1 year) to 0.32 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
PODD:
$9.76B
ARWR:
$11.68B
PODD:
$4.29
ARWR:
-$2.16
PODD:
3.38
ARWR:
18.39
PODD:
7.49
ARWR:
19.50
PODD:
$2.90B
ARWR:
$622.01M
PODD:
$2.06B
ARWR:
$529.27M
PODD:
$529.70M
ARWR:
-$168.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PODD vs. ARWR — Risk / Return Rank
PODD
ARWR
PODD vs. ARWR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PODD | ARWR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -8.13 | ||
| Sortino ratioReturn per unit of downside risk | -7.57 | ||
| Omega ratioGain probability vs. loss probability | 0.72 | 1.68 | -0.97 |
| Calmar ratioReturn relative to maximum drawdown | -0.90 | 17.81 | -18.70 |
| Martin ratioReturn relative to average drawdown | -1.83 | 49.05 | -50.88 |
Loading charts...
Drawdowns
PODD vs. ARWR - Drawdown Comparison
The maximum PODD drawdown since its inception was -90.28%, smaller than the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for PODD and ARWR.
Loading charts...
Drawdown Indicators
| PODD | ARWR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.28% | -99.24% | +8.96% |
Max Drawdown (1Y)Largest decline over 1 year | -60.61% | -24.64% | -35.97% |
Max Drawdown (3Y)Largest decline over 3 years | -60.61% | -74.70% | +14.09% |
Max Drawdown (5Y)Largest decline over 5 years | -61.31% | -88.94% | +27.63% |
Max Drawdown (10Y)Largest decline over 10 years | -61.31% | -88.96% | +27.65% |
Current DrawdownCurrent decline from peak | -60.61% | -49.54% | -11.07% |
Average DrawdownAverage peak-to-trough decline | -25.03% | -81.19% | +56.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.61% | 8.93% | +20.68% |
Volatility
PODD vs. ARWR - Volatility Comparison
Insulet Corporation (PODD) and Arrowhead Pharmaceuticals, Inc. (ARWR) have volatilities of 13.48% and 14.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PODD | ARWR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.48% | 14.13% | -0.65% |
Volatility (6M)Calculated over the trailing 6-month period | 30.88% | 36.34% | -5.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.58% | 65.46% | -26.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.82% | 65.02% | -22.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.55% | 74.19% | -31.64% |
Dividends
PODD vs. ARWR - Dividend Comparison
Neither PODD nor ARWR has paid dividends to shareholders.
Financials
PODD vs. ARWR - Financials Comparison
This section allows you to compare key financial metrics between Insulet Corporation and Arrowhead Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PODD and ARWR have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARWR has higher volatility (14.13%) compared to PODD (13.48%). In terms of maximum drawdown, PODD dropped -90.28% vs ARWR's -99.24%.
ARWR currently has the higher Sharpe Ratio (6.72 vs -1.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PODD and ARWR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer